Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Current Drug Targets|November 13, 2012
Apigenin Modulates Insulin-like Growth Factor Axis: Implications for Prevention and Therapy of Prostate CancerMelissa A Babcook, Sanjay Gupta
The AAPS Journal|December 6, 2013
Plant phytochemicals as epigenetic modulators: role in cancer chemopreventionVijay S Thakur, Gauri Deb, Melissa A Babcook, et al.
Nutrition and Metabolic Insights|July 22, 2016
Statin Use in Prostate Cancer: An UpdateMelissa A Babcook, Aditya Joshi, Jeniece A Montellano, et al.
Carcinogenesis|September 27, 2013
Apigenin inhibits prostate cancer progression in TRAMP mice via targeting PI3K/Akt/FoxO pathwaySanjeev Shukla, Natarajan Bhaskaran, Melissa A Babcook, et al.
The Prostate|March 27, 2018
Ser-486/491 phosphorylation and inhibition of AMPKα activity is positively associated with Gleason score, metastasis, and castration-resistance in prostate cancer: A retrospective clinical studyMelissa A Babcook, Mahmut Akgul, Seunghee Margevicius, et al.
Plos One|January 4, 2013
Green tea polyphenols induce p53-dependent and p53-independent apoptosis in prostate cancer cells through two distinct mechanismsKarishma Gupta, Vijay S Thakur, Natarajan Bhaskaran, et al.
The Prostate|April 5, 2016
Obesity-initiated metabolic syndrome promotes urinary voiding dysfunction in a mouse modelQiqi He, Melissa A Babcook, Sanjeev Shukla, et al.
Molecular Cancer Therapeutics|August 15, 2014
Synergistic simvastatin and metformin combination chemotherapy for osseous metastatic castration-resistant prostate cancerMelissa A Babcook, Sanjeev Shukla, Pingfu Fu, et al.
NPJ Precision Oncology|September 17, 2024
FGFR2-fusions define a clinically actionable molecular subset of pancreatic cancerLeah Stein, Karthikeyan Murugesan, Julie W Reeser, et al.
International Journal of Cancer|August 19, 2024
Representation of women in clinical trials supporting FDA-approval of contemporary cancer therapiesSujay Kalathoor, Sanam Ghazi, Beryl Otieno, et al.
Pageof 2